MD Biosciences Blog

 MD Biosciences has extensive experience in the application of immunohistochemistry to analysis of markers of interest in tissue. Our validated protocols permit such assessments as lymphocyte analysis, cellular proliferation, cellular activation/differentiation, inflammation, biomarker analysis, and much more.

View high-resolution whole slide image examples of our IHC staining results below!

https://www.mdbhistopath.com/immunohistochemistry-image-gallery-ihc-markers 

Don't see a marker you're interested in? We provide custom IHC assay development and validation using either commercially available or Sponsor-provided antibodies, and additionally have in-house antibody development facilities for challenging targets. Contact us to discuss a custom project! 

Our new histopathology website is now live! Check it out here!

MD Biosciences Laboratories offer a broad range of histology, immunohistochemistry (IHC) and In-situ hybridization services, staining services, tissue processing and digital pathology to enhance readouts and study applicability to the clinic.

We operate two distinct histology and IHC laboratories, including a GLP developmental research laboratory and a CLIA clinical IHC laboratory, offering a broad range of state-of-the-art technical capabilities to meet research and clinical study needs. Method development and optimization in addition to routine analysis shapes the foundation for our tissue-based services. The laboratories are equipped with advanced automated staining systems and digitized imaging, facilitating the privileged access to large, annotated image files. Services are complimented by the Visiopharm artificial intelligence-based image analysis platform to enhance the quality and speed of analysis. Services are supported by expert consultant pathologists specialized in various areas. 

Contact us to learn more about our services!

Nes Ziona, Israel & Oakdale, MN, USA

MD Biosciences is pleased to announce OECD Good Laboratory Practices (GLP) Certification for it’s integrated histopathology and IHC facilities located at the Weizmann Science Park in Israel.

MD Biosciences Histopathology and IHC laboratories assist sponsors in the identification and development of clinically relevant biomarker assays and novel methods. The laboratories provide services for a wide variety of tissue types such as skin, joint, neuronal or others from human, porcine, rodent and other species. 

This GLP certification for Histopathology and Toxicological Pathology follows GLP certification of MD Biosciences’ in vivo Preclinical Animal Research Facilities, as well as recognition according to Clinical Laboratory Improvement Amendment (CLIA) provisions for MD Biosciences Clinical Biomarker and Diagnostics Division.

About MD Biosciences:

MD Biosciences is a leading provider of clinical and preclinical contract research services.  Established in 1991, MDB provides expertise and services in areas including cancer, cardiovascular, metabolic, inflammatory and neurological conditions including pain-associated disease as well as surgical procedures. Through collaborations with pharmaceutical and medical device pioneers, MDB develops innovative therapeutics and diagnostic assays. Each scientist at MDB is highly specialized, and has an in-depth understanding of a variety of disease mechanisms and how to modulate them. This expertise, strengthened with over 10 years of preclinical efficacy experience, brings value to drug development programs whether the focus is on new therapies or repositioning approved, expiring or failed therapies. Furthermore, MDB's clinical services operate at state of the art laboratories staffed with highly experienced scientists and technicians utilizing the newest and most advanced equipment available. All clinical work is performed according to CLIA standards, and may include assay development and validation, protocol design, sample archiving, and biomarker analysis services. 

For additional information related to our QC/QA divisions, please email info-us@mdbiosciences.com, Attention: Quality Division.